How Many Med Spas Offer Semaglutide and Other GLP-1s? By State and City

About one in three US med spas now names semaglutide, tirzepatide or another GLP-1 treatment on its own website. Of the 5,497 clinics on AuraVenu whose treatment list comes from their own website or owner, 1,931 do. How common it is depends heavily on where you live: the share in Massachusetts is more than double the share in New York.

To see who offers it near you, browse semaglutide and GLP-1 providers by state and city. For the wider picture of the industry, see our US med spa statistics.

How GLP-1 compares with other treatments

GLP-1 is now a mainstream part of the med spa menu, though well behind the core aesthetic treatments. Botox appears at 88% of these clinics, microneedling at 84% and dermal fillers at 80%. At 35%, GLP-1 treatment is about level with IV therapy, at 36%, and well ahead of Morpheus8 and CoolSculpting, at 20% each. It ranks 18th of the 39 treatments we track. A broader group, 39% of clinics, advertises a weight-loss program of some kind.

The share of med spas naming GLP-1 treatment, by state

1. Massachusetts46 clinics57%
2. Colorado47 clinics53%
3. Ohio54 clinics48%
4. Arizona84 clinics46%
5. North Carolina71 clinics42%
6. Florida1,376 clinics42%
7. Connecticut54 clinics41%
8. Oregon32 clinics41%
9. Nevada59 clinics39%
10. Texas348 clinics39%
11. Georgia385 clinics38%
12. Illinois527 clinics37%
13. Maryland179 clinics35%
14. New Jersey91 clinics33%
15. Michigan108 clinics32%
16. Washington233 clinics31%
17. Pennsylvania196 clinics30%
18. Tennessee47 clinics30%
19. Virginia202 clinics30%
20. Minnesota145 clinics28%
21. California834 clinics26%
22. New York117 clinics25%
23. 0%10%20%30%40%50%60%

Share of clinics in each state whose treatment list comes from their own website or owner. States with at least 30 such clinics.

Massachusetts, Colorado, Ohio and Arizona lead, with nearly half or more of their clinics naming a GLP-1. New York and California have the lowest shares, at 25% and 26%, even though California has the most clinics in this data after Florida. In Florida, the largest group here with 1,376 clinics, the share is 41%, and in Texas it is 39%.

The share by city

1. Denver45 clinics56%
2. Boston44 clinics55%
3. Columbus38 clinics50%
4. Orlando239 clinics50%
5. Phoenix46 clinics48%
6. San Antonio73 clinics47%
7. Los Angeles410 clinics27%
8. Minneapolis138 clinics27%
9. New York City115 clinics25%
10. Bethesda66 clinics24%
11. San Jose106 clinics23%
12. San Francisco169 clinics21%
13. 0%10%20%30%40%50%60%

The six highest and six lowest of 33 metros with at least 30 clinics whose treatment list comes from their own website or owner. Follow a city to compare its providers.

Neighboring markets can differ widely. Orlando’s 50% is well above Miami’s 38%, in the same state. In Texas, San Antonio is at 47% and Austin at 35%. All three California metros in the lowest group, Los Angeles, San Jose and San Francisco, sit at or below 27%.

Our data shows where clinics offer GLP-1 treatment, not why. It cannot tell us whether a low share reflects local demand, a focus on aesthetic treatments, or something else.

What to know before you book

The FDA has approved GLP-1 products for weight management, including Wegovy (semaglutide) and Zepbound (tirzepatide). Clinics and telehealth services may also offer compounded versions. The FDA says that compounded drugs are not FDA-approved, and that the agency does not review them for safety, effectiveness or quality before they are marketed.

A clinic’s website often does not say which it offers, and our data does not separate the two. So ask directly.

How we got these numbers

• The sourceAuraVenu’s US listings as of November 3, 2026: 7,588 med spas and aesthetic clinics. Treatment lists come from each clinic’s own website, or from owners who claim their listing.
• The baseShares cover the 5,497 clinics with that kind of treatment data, not every listing. A clinic we could not read is left out rather than counted as a no.
• What counts as GLP-1A clinic counts if its site names semaglutide, tirzepatide, GLP-1, a brand such as Ozempic, Wegovy, Mounjaro or Zepbound, or weight-loss injections. This is what clinics advertise. We did not check prescribing or stock.
• Enough clinics to be fairA state or metro needs at least 30 clinics with treatment data before we show it.
• Coverage changed this monthWe added thousands of listings in November, mostly in ten large metros. Do not compare this share with our October figure, because the group of clinics is different.

You can download the figures as CSV files: by state and by metro. They are free to reuse with credit to AuraVenu.

Frequently asked questions

How many med spas offer semaglutide?

In our November 2026 data, 1,931 of 5,497 US clinics, or 35%, name semaglutide, tirzepatide or another GLP-1 treatment on their own website or through their owner. Those are the clinics on AuraVenu with treatment data from those sources, not every med spa in the country.

Which state has the most med spas offering GLP-1s?

By share, Massachusetts is highest at 57%, followed by Colorado at 53% and Ohio at 48%. By count, Florida has the largest group in our data, with 41% of its 1,376 clinics naming a GLP-1. States with fewer than 30 clinics with treatment data are not ranked.

Which cities have the highest share?

Denver at 56% and Boston at 55% lead the metros we can measure, followed by Columbus and Orlando at 50%. San Francisco has the lowest share, at 21%. These figures cover metros with at least 30 clinics with treatment data.

Are GLP-1 medications from a med spa FDA-approved?

It depends on the product. Wegovy and Zepbound are FDA-approved for weight management, while the FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before marketing. Ask the clinic which one it provides and for the medication’s name.

Compare semaglutide and GLP-1 providers near you